BIO-TECHNE Corp 4
4 · BIO-TECHNE Corp · Filed Jul 11, 2017
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Gould Kevin S
SVP Clinical Controls
Transactions
- Tax Payment
Common Stock
2017-07-09$117.68/sh−312$36,716→ 1,355 total
Holdings
- 17,371
Stock Options (Right to Buy)
Exercise: $106.59Exp: 2023-08-18→ Common Stock (17,371 underlying) - 2,111
Restricted Stock Units
→ Common Stock (2,111 underlying) - 13,028
Stock Options (Right to Buy)
Exercise: $106.59Exp: 2023-08-18→ Common Stock (13,028 underlying) - 50,000
Stock Options (Right to Buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (50,000 underlying) - 15,000
Stock Options (Right to Buy)
Exercise: $97.23Exp: 2022-07-09→ Common Stock (15,000 underlying) - 10,000
Stock Options (Right to Buy)
Exercise: $88.23Exp: 2023-01-04→ Common Stock (10,000 underlying)
Footnotes (7)
- [F1]Includes 834 shares of restricted stock units that vest on 7/9/18.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F3]Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F4]Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- [F5]50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/18.
- [F6]Vests as to 3,750 shares on each of 7/9/16, 7/9/17, 7/9/18 and 7/9/19.
- [F7]Vests as to 2,500 shares on each of 01/04/17, 01/04/18, 01/04/19 and 01/04/20.